Biodesix

Biodesix EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Biodesix (BDSX) as of Oct 18, 2026 is -6.23. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -2.61 — a change of 138.95% (lower).

EV/OCF

-6.23

YoY

138.95%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Biodesix is 2025 -6.23 . EV/OCF (Enterprise Value to Operating Cash Flow) of Biodesix was 2024 -2.61 . It decreases by 138.95% lower compared to the previous year.

The Biodesix EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
-6.13 USD
Jan 1, 2019
-5.61 USD
Jan 1, 2020
-2.66 USD
Jan 1, 2021
-2.42 USD
Jan 1, 2022
-1.78 USD
Jan 1, 2023
-5.49 USD
Jan 1, 2024
-2.61 USD
Jan 1, 2025
-6.23 USD
The Biodesix EV/OCF history
YEAREV/OCFYoY
-6.23+138.95%
-2.61-52.49%
-5.49+209.04%
-1.78-26.73%
-2.42-8.74%
-2.66-52.63%
-5.61-8.49%
-6.13—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biodesix Stock analysis

What does Biodesix do? Biodesix Inc., headquartered in Boulder, Colorado, operates in the Health Care sector, providing blood-based diagnostic services for lung disease patients. The company employs 245 full-time staff and offers diagnostic testing solutions including Nodify XL2, Nodify CDT, GeneStrat, and VeriStrat tests for lung conditions, alongside SARS-CoV-2 testing under the Biodesix WorkSafe program. Listed on October 28, 2020, Biodesix leverages AI technology to develop clinical solutions for unmet needs in lung disease, serving both patients and biopharmaceutical partners through contract-based services. Biodesix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biodesix stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Biodesix is -6.23 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Biodesix changed from -2.61 to -6.23, representing a 138.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Biodesix since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Biodesix with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Biodesix

All Key Metrics — Biodesix